Clinigen Group PLC (LON:CLIN) insider Shaun Edward Chilton sold 100,000 shares of the stock in a transaction that occurred on Friday, October 13th. The shares were sold at an average price of GBX 1,150 ($15.28), for a total value of £1,150,000 ($1,528,036.14).

Shares of Clinigen Group PLC (LON:CLIN) opened at 1120.00 on Wednesday. Clinigen Group PLC has a one year low of GBX 695.00 and a one year high of GBX 1,175.00. The stock has a 50 day moving average price of GBX 1,108.08 and a 200 day moving average price of GBX 952.65. The stock’s market capitalization is GBX 1.29 billion.

Clinigen Group PLC (LON:CLIN) last released its quarterly earnings data on Thursday, September 28th. The company reported GBX 41.80 ($0.56) EPS for the quarter, beating analysts’ consensus estimates of GBX 41.20 ($0.55) by GBX 0.60 ($0.01). Clinigen Group PLC had a return on equity of 0.98% and a net margin of 0.70%. The firm had revenue of £302.30 million for the quarter.

The firm also recently disclosed a dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be issued a GBX 3.40 ($0.05) dividend. The ex-dividend date is Thursday, November 9th. This is a boost from Clinigen Group PLC’s previous dividend of $1.60. This represents a yield of 0.32%.

ILLEGAL ACTIVITY WARNING: “Shaun Edward Chilton Sells 100,000 Shares of Clinigen Group PLC (CLIN) Stock” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/18/shaun-edward-chilton-sells-100000-shares-of-clinigen-group-plc-clin-stock.html.

CLIN has been the subject of several analyst reports. Peel Hunt reaffirmed an “add” rating and issued a GBX 1,200 ($15.94) price objective on shares of Clinigen Group PLC in a research note on Thursday, September 28th. Numis Securities Ltd lowered Clinigen Group PLC to an “add” rating and set a GBX 1,100 ($14.62) price objective for the company. in a research note on Tuesday, July 18th.

About Clinigen Group PLC

Receive News & Stock Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related stocks with our FREE daily email newsletter.